Alireza P Shabanzadeh Selected Research

Cerebral Infarction

11/2006

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alireza P Shabanzadeh Research Topics

Disease

5	Stroke (Strokes) 04/2018 - 04/2005
5	Infarction (Infarctions) 05/2011 - 04/2005
4	Spinal Cord Injuries (Spinal Cord Injury) 04/2021 - 08/2014
3	Brain Injuries (Brain Injury) 05/2011 - 04/2005
2	Neuralgia (Stump Neuralgia) 04/2021 - 06/2020
2	Hyperalgesia 04/2021 - 06/2020
2	Optic Nerve Injuries 01/2021 - 01/2019
2	Ischemia 04/2018 - 04/2005
2	Hyperthermia 09/2010 - 09/2008
1	Pain (Aches) 04/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021
1	Spinal Cord Compression 10/2020
1	Retinal Degeneration 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2019
1	Reperfusion Injury 04/2018
1	Brain Infarction 05/2011
1	Vomiting 05/2011
1	Brain Ischemia (Cerebral Ischemia) 09/2008
1	Ischemic Stroke 11/2006
1	Cerebral Infarction 11/2006
1	Brain Edema (Cerebral Edema) 04/2005

Drug/Important Bio-Agent (IBA)

4	Small Interfering RNA (siRNA)IBA 04/2021 - 01/2019
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2021 - 06/2020
3	metabotropic glutamate receptor 8IBA 04/2021 - 06/2020
2	CholesterolIBA 01/2021 - 08/2014
2	neogeninIBA 01/2021 - 01/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 09/2008
2	LigandsIBA 01/2021 - 11/2006
2	Glutamic Acid (Glutamate)FDA Link 10/2020 - 11/2006
2	Rosiglitazone (Avandia)FDA Link 09/2010 - 11/2006
2	Simvastatin (Zocor)FDA LinkGeneric 09/2008 - 04/2005
1	metabotropic glutamate receptor 2IBA 04/2021
1	2-amino-4-phosphono-propinateIBA 04/2021
1	LipidsIBA 01/2021
1	Saline SolutionIBA 06/2020
1	RNA (Ribonucleic Acid)IBA 06/2020
1	AcetoneIBA 06/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	IntegrinsIBA 01/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2018
1	Retinaldehyde (Retinal)IBA 04/2018
1	salicylhydroxamic acid (SHAM)IBA 04/2018
1	methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA 04/2018
1	1-(3-chlorophenyl)biguanideIBA 05/2011
1	Tropisetron (Navoban)IBA 05/2011
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011
1	Peroxidase (Myeloperoxidase)IBA 05/2011
1	Dizocilpine Maleate (Dizocilpine)IBA 09/2010
1	Neuroprotective AgentsIBA 09/2010
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2006
1	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2006
1	ThiazolidinedionesIBA 11/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2006
1	PPAR gammaIBA 11/2006
1	Coloring Agents (Dyes)IBA 04/2005
1	Protective AgentsIBA 04/2005

Therapy/Procedure

1	Aftercare (After-Treatment) 04/2021
1	Surgical Instruments (Clip) 04/2021
1	Ligation 04/2018
1	Therapeutics 04/2018
1	Drug Therapy (Chemotherapy) 05/2011